Cardiometabolic Disease
The association between obesity, cardiometabolic disease biomarkers, and innate immunity-related inflammation in Canadian adults
... between cardiometabolic biomarkers and obesity in different ethnocultural groups, given known differences in cardiometabolic disease rates in different ...of cardiometabolic and inflamma- tory ...
9
Cardiometabolic disease risk and HIV status in rural South Africa : establishing a baseline
... Sub-Saharan Africa is facing parallel and interacting epi- demics of HIV and cardiometabolic disease risk that are fuelled by complex health and social transitions. Our results indicate both a high ...
10
Relationship between blood pressure values, depressive symptoms and cardiovascular outcomes in patients with cardiometabolic disease
... with cardiometabolic disease (coronary heart disease [CHD], diabetes, and previous stroke), as it is associated with a reduction in the risk of future adverse cardiovascular (CV) out- ...existing ...
9
Combining Wireless Technology and Behavioral Economics to Engage Patients (WiBEEP) with cardiometabolic disease: a pilot study
... of cardiometabolic diseases, such as type 2 diabetes and hypertension, is complex and can be facilitated by supporting patient-directed behavioral ...managing cardiometabolic diseases, although promising, ...
6
Statins in cardiometabolic disease: what makes pitavastatin different?
... This article has been published as part of Cardiovascular Diabetology Volume 12 Supplement 1, 2013: Statins in cardiometabolic disease: what makes pitavastatin diff erent? The full contents of the ...
6
Identification of Matrix Metalloproteinase-12 as a Candidate Molecule for Prevention and Treatment of Cardiometabolic Disease
... MMP12 can degrade different con- stituents of the extracellular matrix, playing an essential role in the extra- cellular matrix remodeling process. (31,42) Notably, casein zymography has revealed increased caseinolytic ...
10
Prevalence of frailty, cognitive impairment, and sarcopenia in outpatients with cardiometabolic disease in a frailty clinic
... with cardiometabolic disease at baseline will help us to explore risk factors for the progression of frailty and cognitive decline in an ongoing 3-year longitudinal pro- spective observational study ...
11
Pitavastatin in cardiometabolic disease: therapeutic profile
... the cardiometabolic lipid profi le and its low potential for drug–drug interactions, this suggests that pitavastatin might be a useful lipid-lowering option for people with cardiometabolic ...
8
Food for microbes. The interplay between indigestible carbohydrates, gut microbiota, and cardiometabolic disease
... of cardiometabolic risk factors and disease, including obesity, type 2 diabetes, and ...of cardiometabolic disease, it was important to have the ability to determine blood lipid ...
291
The wrong white crystals: not salt but sugar as aetiological in hypertension and cardiometabolic disease
... Coincidentally, processed foods happen to be major sources of not just sodium but of highly re fi ned carbohy- drates: that is, various sugars, and the simple starches that give rise to them through digestion. Compelling ...
8
Percentile curves for cardiometabolic disease markers in Canadian children and youth: a cross-sectional study
... Blood for measurement of cardiometabolic markers was collected by standard venipuncture. Fasted blood samples for measurement of insulin, glucose, and tri- glycerides were taken in a randomly selected sample of ...
11
Impediments to clinical application of exercise interventions in the treatment of cardiometabolic disease
... S tatins have become a pharmacologic cornerstone for the prevention and treatment of cardiovascular disease (CVD). However, it is clear from the large statin trials that maximal lowering of low-density lipo- ...
7
Maternal undernutrition and cardiometabolic disease: a latin american perspective
... Besides the molecular and cellular levels, there are some gene-specific mechanisms operating at the level of individual genes and gene subsets. Several TF and extra- genic noncoding RNAs participate in the induction of ...
11
Carotid body chemoreceptors, sympathetic neural activation, and cardiometabolic disease
... Metabolic syndrome is a growing health problem world- wide, with a high prevalence and strong associations with cardiovascular risk and diabetes. Autonomic dysfunction, characterized by sympathetic hyperactivity, vagal ...
9
Sleep duration, cardiovascular disease, and proinflammatory biomarkers
... with cardiometabolic disease, via several mechanistic pathways, but few have been thoroughly ...cardiovascular disease, and proinflammatory ...cardiovascular disease, is ...cardiovascular ...
15
PubMedCentral-PMC5035202.pdf
... Nonalcoholic steatohepatitis is a rapidly growing public health concern characterized by progressive hepatic inflammation, injury, and fibrosis; however, the key pathways that regulate its development and progression ...
24
1-s2.0-S0033062020300359-main.pdf
... in cardiometabolic disease biomarkers and outcomes is different for PLWH versus those without ...metabolic disease biomarkers/diagnoses are most in fl uenced by PA pat- terns in this ...and ...
8
Shared genetic underpinnings of childhood obesity and adult cardiometabolic diseases
... adult cardiometabolic disease traits overlap could provide new avenues for therapeutic ...metabolic disease-related ontologies and potential drug targets among the set of genes jointly associated ...
9
Childhood Assets and Cardiometabolic Health in Adolescence
... problems. Cardiometabolic health was assessed at ages 9 and 17 by using a composite dysregulation score derived from multiple biological parameters, including cholesterol, blood pressure, C-reactive protein, ...
12
Repeat Antenatal Betamethasone and Cardiometabolic Outcomes
... repeat antenatal betamethasone therapy was not associated with any adverse effects on cardiometabolic function. Thus, it seems unlikely that the catch-up in height seen with repeat betamethasone in the FGR ...
13